GALVESTON, Texas, Aug. 21, 2019 /PRNewswire/ -- Chrysalis BioTherapeutics, Inc. today announced that the US Food and Drug Administration (FDA) Office of Orphan Product Development and the European Medicines Agency (EMA) have granted Orphan Drug Designation (ODD) to the company's lead compound, TP508 (rusalatide acetate) for the treatment of acute radiation syndrome

TOKYO and NEW YORK, Aug. 21, 2019 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the filing of a supplemental New Drug Application

PARAMUS, N.J., Aug. 21, 2019 /PRNewswire/ -- Steve White, CEO of Harvest Health & Recreation, will deliver a Keynote Address, entitled: "Doing Well by Doing Good," at the 6th Annual

COLORADO SPRINGS, Colo., Aug. 21, 2019 /PRNewswire/ -- Break the Silence Against Domestic Violence's 2019 Angel Fund made the biggest impact yet. Bereaved families ac

WASHINGTON, Aug. 21, 2019 /PRNewswire/ -- The following statement was issued by Dan Stein, president of the Federation for American Immigration Reform (FAIR), in response to the announcement from the Department of Homeland Security and the Department of Health and Human Services on a final rule that will allow for the termina

The technology should reduce costs to patients and accelerate drug development   BEDFORD, Mass., Aug. 21, 2019 /PRNewswire/ -- Conagen, a vertically integrated synthetic biology company located in Boston's biotech corridor, announced today that it has acquired a fermentation-based technology for the product

BIRMINGHAM, Ala., Aug. 21, 2019 /PRNewswire/ -- Therapy Brands is excited to welcome Shannon Vann as the VP of Marketing. Vann joins the Therapy Brand

DETROIT, Aug. 21, 2019 /PRNewswire/ -- eSimplify, a market-leading provider of Family Practice healthcare analytics that enables small and medium sized Family Practice and Internal Medicine Groups

NEW YORK, Aug. 21, 2019 /PRNewswire/ -- A newly published carefully-researched and meticulously peer-reviewed US government-funded study published in 

SEATTLE, Aug. 21, 2019 /PRNewswire/ -- A new study from the Allen Institute for Brain Science has written the most detailed "parts list" of the human brain to date. This categorization of our brain cell types lays the groundwork to improve our understanding of our own brains and to dramatically change how we treat human brain diseases and disorders.